Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report)'s stock price reached a new 52-week high during trading on Tuesday . The stock traded as high as $49.96 and last traded at $46.49, with a volume of 326699 shares traded. The stock had previously closed at $45.00.
Analyst Ratings Changes
A number of equities analysts have issued reports on the company. Fundamental Research set a $60.23 target price on Zepp Health and gave the company a "buy" rating in a research report on Tuesday, August 26th. Wall Street Zen raised Zepp Health to a "hold" rating in a research report on Saturday, August 16th. One equities research analyst has rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $60.23.
View Our Latest Report on ZEPP
Zepp Health Stock Performance
The company has a current ratio of 1.10, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $719.88 million, a price-to-earnings ratio of -10.28 and a beta of 1.33. The company has a 50-day moving average of $23.22 and a 200-day moving average of $9.82.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Featured Stories
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.